Blue Jet Healthcare Limited (BLUEJET) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.165x

Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has a cash flow conversion efficiency ratio of 0.165x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.07 Billion ≈ $22.41 Million USD) by net assets (Rs12.56 Billion ≈ $135.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Blue Jet Healthcare Limited balance sheet independence to measure how much of total assets are equity-financed.

Blue Jet Healthcare Limited - Cash Flow Conversion Efficiency Trend (2020–2026)

This chart illustrates how Blue Jet Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Blue Jet Healthcare Limited to evaluate the quality of earnings relative to operating cash generation.

Blue Jet Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Blue Jet Healthcare Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Akasha Wira International Tbk JK:ADES	0.056x
Ami Organics Limited NSE:AMIORG	0.006x
Ramsay Generale De Sante PA:GDS	0.060x
Olectra Greentech Limited NSE:OLECTRA	-0.028x
Ribo Fashion Group Co Ltd SHG:603196	0.088x
HBM HLDGS LTD DL-000025 F:6XY	N/A
Hagerty Inc NYSE:HGTY	0.021x
Hemab Therapeutics Holdings, Inc. Common Stock NASDAQ:COAG	N/A

Annual Cash Flow Conversion Efficiency for Blue Jet Healthcare Limited (2020–2026)

The table below shows the annual cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Blue Jet Healthcare Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs13.60 Billion ≈ $147.07 Million	Rs3.38 Billion ≈ $36.56 Million	0.249x	+515.48%
2025-03-31	Rs11.33 Billion ≈ $122.54 Million	Rs457.65 Million ≈ $4.95 Million	0.040x	-85.85%
2024-03-31	Rs8.45 Billion ≈ $91.41 Million	Rs2.41 Billion ≈ $26.09 Million	0.285x	+37.42%
2023-03-31	Rs6.81 Billion ≈ $73.70 Million	Rs1.42 Billion ≈ $15.31 Million	0.208x	-26.01%
2022-03-31	Rs5.22 Billion ≈ $56.40 Million	Rs1.46 Billion ≈ $15.83 Million	0.281x	-26.57%
2021-03-31	Rs3.40 Billion ≈ $36.75 Million	Rs1.30 Billion ≈ $14.05 Million	0.382x	-36.84%
2020-03-31	Rs2.03 Billion ≈ $21.93 Million	Rs1.23 Billion ≈ $13.27 Million	0.605x	--

About Blue Jet Healthcare Limited

NSE:BLUEJET India Biotechnology

Market Cap

$1.17 Billion

Rs108.63 Billion INR

Market Cap Rank

#8090 Global

#405 in India

Share Price

Rs626.25

Change (1 day)

+2.25%

52-Week Range

Rs327.25 - Rs805.10

All Time High

Rs1010.20